The U.S. FDA has approved Alhemo, given as once-daily injections, to help prevent bleeds in patients with hemophilia A or B ...

Hemophilia News Today compiled a summary of the 10 most read hemophilia stories of 2024, with links to the individual items.

While she's still learning to navigate life with ADHD, columnist Alliah Czarielle has found that the condition benefits her as a caregiver.

Columnist Joe MacDonald remembers the Christmas spent with his family in the hospital as his youngest son endured a bleeding episode.

Columnist Jennifer Lynne knows that finding a sense of community can be challenging, but she's also learned it's worth it.

Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...

Preventive treatment with Altuviiio led to lower bleed rates and better joint health than Hemlibra in hemophilia A patients ...

The first-in-human Phase 1/2 clinical trial testing BE-101, Be Biopharma’s B-cell treatment candidate for hemophilia B, is now enrolling patients at two sites in the U.S. BE-101, a first-in-class ...